|
市場調査レポート
医薬品業界における患者の指示順守度と病気管理：プログラム開発、管理および改善
Pharmaceutical Patient Adherence and Disease Management: Program Development, Management and Improvement
|
当商品の販売は、2011年12月09日を持ちまして終了しました。
Abstract
Increase the effectiveness of your patient adherence and disease management
programs:
This report provides benchmarks for patient adherence and disease management
organizational structures, resource investments, tactics and improvement
processes. Explore some of the industry' s most innovative programs, from
leadership involvement to budgets to common program challenges.
Pharmaceutical Patient Adherence and Disease Management is designed in a
reader-friendly format so you can easily access information according to
interest and need. The report is broken down into four chapters:
- Structures, Headcounts and Investment - Learn how industry leaders draw on
multiple functions to develop well-rounded campaigns. Explore timing of team
assembly and investment levels of various programs.
- Program Management - Discover how the most successful programs rely on
market research to develop customized messages and launch targeted efforts
across various media channels. Study companies' strategies to achieve patient
buy-in and overcome program challenges.
- Opportunity and Improvement - Investigate the business opportunity of
addressing non-adherence. Uncover companies' strategies and tactics to improve
their initiatives and the latest innovations on the adherence front.
- Real-World Program Details - Analyze real-world programs' resources,
compliance rates, development timeframes and media mixes.
Table of Contents
Chapter 1:
- Percentage of companies' portfolios supported by patient adherence programs
- Percentage of companies' portfolios supported by disease management
programs
- Functions involved in program development and maintenance
- Program team leadership
- Team sizes throughout program launch and maintenance
- Lifecycle stage in which companies assemble program teams
- Percentage of programs' development budgets that are outsourced
- Percentage of companies outsourcing specific program activities
- Investment in program development from concept to implementation
- Annual program maintenance investment
Chapter 2:
- Percentage of companies that have non-branded disease awareness campaigns
- Percentage of companies leveraging various media channels
- Examples of pharmaceutical adherence tools
- Companies' ratings of program challenges
- Percentage of companies with outcome measurements in place to measure ROI
Chapter 3:
- Percentage of average drugs' foregone sales due to adherence issues
- Brand websites most visited by physicians
Chapter 4 contains 18 program profiles, which each contain the
following metrics and graphics:
- Program background information: condition status, global launch,
brand/therapeutic area peak annual sales
- Percentage of patients compliant at various treatment stages
- Cost to attain a new patient vs. cost to retain an existing patient
- Percentage of current overall marketing budget spent on patient
adherence/disease management
- Program funding sources
- Development budget vs. annual maintenance budget
- Percentage of development budget spent on various program activities
- Media channels leveraged in campaign
- Percentage of development budget that was outsourced
- Staff support at various program stages
- Timing of key program development activities
- ROI measurements
|
